Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Krueger, C. Schumann, R. Marre, N. Suttorp, T. Welte (Aachen, Ulm, Berlin, Hannover, Germany). Clinical characteristics and symptoms in older and younger patients with community acquired pneumonia. Eur Respir J 2008; 32: Suppl. 52, 1848

Member's Comments

No comment yet.

Related content which might interest you: Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Clinical features of COVID-19 pneumonia in elderly patients Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004 Clinical signs and symptoms as predictors of pneumonia in hospitalized children Source: Annual Congress 2008 - Miscellaneous respiratory infections Year: 2008 Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Significance of comorbidity in elderly patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006 Clinical characteristics of pneumonia in the elderly Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged >=75 yrs Source: Eur Respir J 2001; 17: 200-205 Year: 2001 Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Outcome of community aquired pneumonia in elderly patients Source: Eur Respir J 2006; 28: Suppl. 50, 530s Year: 2006 Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 Influence of older age on biomarker concentrations in patients with community acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Difficult diagnosis of severe community acquired pneumonia in young people Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Clinical characteristics and outcomes of hospitalized COVID-19 pneumonia : impact of gender Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 Severity assessment in adults patients aged <50 years admitted with community acquired pneumonia Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Severity and outcome of community acquired pneumonia in asthmatic patients Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Clinical background in young adult patients hospitalized with severe asthma exacerbation –Comparison of the present with 10 years ago– Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases Year: 2010 Characteristics of younger versus elderly patients with pulmonary tuberculosis diagnosed at respiratory department Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020